Navigation Links
Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets
Date:6/16/2008

BALTIMORE, June 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Escitalopram Oxalate Tablets 10 mg and 20 mg from the U.S. Food and Drug Administration (USFDA).

Lupin's Escitalopram tablets are the AB-rated generic equivalent of Forest Laboratories' Lexapro(R) tablets, indicated for the treatment of major depressive disorder. The brand product had annual sales of approximately $2.6 billion for the twelve months ended March 2008, based on IMS Health sales data.

Commenting on the approval, Vinita Gupta, President and Managing Director of Lupin Pharmaceuticals, Inc. said, "We are pleased to receive this tentative approval and look forward to bringing Escitalopram tablets to the US market as an affordable generic alternative post patent expiry."

The product will be introduced in the market through LPI's strong network of national wholesalers and drug stores post patent expiry in March 2012. This will strengthen Lupin's presence in the Selective Serotonin Reuptake Inhibitor (SSRI) segment.

About Lupin

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabetology, Asthma and NSAIDs.

The Company's R&D endeavors have resulted in significant progress in its NCE program. The Company's foray into New Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals.

For the financial year ended March 2008, the Lupin's Revenues and Profit after Tax were Rs.27,730 milli
'/>"/>

SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lupin Launches Ramipril Capsules
2. Lupin Receives USFDA Approval for Topiramate Tablets
3. Alexian Brothers Hospital Network Receives American Stroke Associations Get With The Guidelines Gold Performance Achievement Award
4. Mindrays AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance
5. Sam Schmidt Receives a Honda Odyssey Converted for Wheelchair Accessibility
6. USC physician Anne L. Peters receives American Diabetes Associations Distinguished Clinician Award
7. Country Music Superstar, Sara Evans, Receives Red Cross National Award
8. ISI Receives New ISO 9001:2000 Certifications in California and New Jersey
9. Siemens SOMATOM Definition AS Receives FDA Clearance
10. OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
11. Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN), ... $1.6 billion peripheral nerve repair market, reported record revenue ... 31, 2015 compared to $3.14 million in the year-ago ... our proprietary portfolio of nerve repair products - ... Protector – and our solid sales execution delivered another ...
(Date:5/5/2015)... The global lab automation market is expected ... in 2014, at an estimated CAGR of 6.7% from ... market on the basis of equipment and software, application, ... basis of application, Lab Automation Market is classified into ... Drug discovery is a major application of the lab ...
(Date:5/5/2015)... 2015 Viverae®, a health management ... a leading multinational developer, manufacturer and marketer of ... vascular, urology, oncology and surgical specialty products, as ... The Vanguard Award recognizes outstanding achievement in the ... Viverae’s significant client base. , Viverae reviewed the ...
(Date:5/5/2015)... Dr. Patricia George knows all too well the debilitating ... hypertension specialist at the University of Pittsburgh Medical Center ... initial idea entered her mind for Team PHenomenal Hope. ... the 2010 PHA International Conference,” George recalled. “The speakers ... their climb up Mt. Kilimanjaro and I remember thinking ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 In a April ... The Herald-Times , the Missouri State Highway Patrol (MSHP) ... Methamphetamine production or use for the second year in a ... to the FBI, reported 1,469 incidents in 2014 alone, around ... only around 2% of the US Population calls Indiana home, ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2
... 17 Zargis Medical Corp., a spin-off from Siemens Corporate Research ... Corp. (Nasdaq: SPDE ), announced today it has received ... Signal X6(TM) device. Zargis also announced the delivery of seven ... Department of Defense medical facilities. , , Signal ...
... , CHICAGO, Sept. 17 Today, Scott Lee Cohen, ... statewide "Listening Tour." Cohen embarked on Monday, September 14, 2009 from his ... than 40 planned meetings with elected officials and community leaders throughout the ... include:, Winnebago County; Rockford, IL; ...
... ... Novartis Oncology was conducted independently for CURE magazine among 1,365 of its readers living with ... ... -- A new national survey shows that nearly one in three patients with rare cancers ...
... , PITTSBURGH, Sept. 17 ... solutions for individuals with speech, language and learning disabilities, today ... the Year award from Microsoft Corp. This award recognizes ... Microsoft software in their products. , , ...
... , , , , ... SMTS ) today reported net revenues of $12.5 million for the third quarter ... same period of 2008. For the nine months ended August 31, 2009, ... , U.S. net revenues increased 10 percent to $10.4 million from ...
... , OVERLAND PARK, Kan., Sept. 17 Sunlight Saunas(TM) ... of industry firsts, and announce the winner of its 10th Anniversary ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090917/CG77208 ) , , During its ... carbon heating technology to the market. Unlike conventional saunas that use ...
Cached Medicine News:Health News:Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army 2Health News:Cohen Launches Second Statewide Tour 2Health News:New Survey Highlights the Challenges of People Living with Rare Cancer 2Health News:New Survey Highlights the Challenges of People Living with Rare Cancer 3Health News:DynaVox Mayer-Johnson Receives Microsoft Award 2Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 2Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 3Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 4Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 5Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 6Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 7Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 8Health News:Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009 9Health News:Sunlight Saunas Celebrates 10 Years of Industry Firsts, and Announces 10th Anniversary Sweepstakes Winner 2
(Date:5/5/2015)... -- IBM Watson Health (NYSE: IBM ) today announced ... leading cancer institutes to accelerate the ability of clinicians ... The institutes will apply Watson,s ... the ability to translate DNA insights, understand a person,s ... to personalize treatment options. The project is part of ...
(Date:5/5/2015)... 5, 2015 (Family Features) Which health screenings ... like most adults, monitoring your weight, cholesterol, and blood ... But what about vision care? Photo ... reach their 40s, they often start to notice small ... lives and job performance. Whether having difficulty reading a ...
(Date:5/5/2015)... and NIJMEGEN, the Netherlands ... medical device company developing lower esophageal sphincter (LES) ... long-term, 3-year, positive safety and efficacy results. The ... of both heartburn and regurgitation and the "gold-standard" ... test) with near-complete elimination of dependence on daily ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3
... CEO Yaacov Shoham today issued the following statement, ... and asked them to upgrade IDenta,s current tier. They are ... 1. Annual financial report (audited) for year 2011 ( ... Statement The files can be found at the ...
... Mass., April 26, 2012  Sensitech Inc., the global ... the International Air Transport Association (IATA) has deemed ... devices to be in compliance with the 53rd ... Provision (SP) 188 published by the United Nations.   ...
Cached Medicine Technology:International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets. 2Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection....
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g....
... manufactures standard and custom shields and barriers for ... low level or high level radiation shielding, we ... pure lead, lead acrylic, lead glass, lead vinyl ... We can offer shielding from 1/32" thick to ...
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Medicine Products: